Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\333933.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Am+J+Pathol 1977 ; 89 (1): 105-18 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Ultrastructural appearance and morphogenesis of renal glomerular hematoxylin bodies #MMPMID333933
Cohen AH; Zamboni L
Am J Pathol 1977[Oct]; 89 (1): 105-18 PMID333933show ga
The fine morphology of hematoxylin bodies--structures which, by light microscopy, are considered to be pathognomonic for systemic lupus erythematosus--is described in renal glomeruli. These bodies are highly pleomorphic and are predominantly of cellular origin. The nuclear components, which are responsible for the characteristic tinctorial properties, appear as aggregates of clumped chromatin and/or irregular masses of finely granular, moderately dense, lobulated material, generally enveloped by membranes. The cytoplasmic components consist of a multitude of vesicles, vacuoles, degenerating granules, and glycogen. Hematoxylin bodies are usually contained within the bounderies of mesangial cells. A transition from circulating leukocytes to typical hematoxylin bodies could be demonstrated. It is suggested that the changes in leukocytes which culminate in hematoxylin bodies are intiated by the action of antinuclear antibodies and also possibly by the ingestion of immune complexes. This proposed appearance and morphogenesis of hematoxylin bodies is in general agreement with a few previously published investigations on these structures and also with the in vitro counterpart, the lupus erythematosus (LE) cell.